Clinical trial
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer: A Multicenter, Prospective, Randomized Controlled Trial
NCT03152643 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer: A Multicenter, Prospective, Randomized Controlled Trial
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 29, 2018
- Completion date
- February 18, 2022
- Enrollment
- 992 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.